Moran Sean F.
SEC CIK 1451495 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | CFO | 84.7K | $14.3K | $1.27M | 14 | 2022-03-10 | 2026-08-07 |
Most active insiders at CRBP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cohen Yuval | CEO, Dir | — | $750.5K |
| 2 | Moran Sean F. | CFO | — | $378.5K |
| 3 | Chen Bihua | 10% | — | $344.1K |
| 4 | Saxena Nishant C | Chief Business Off | $126.3K | — |
| 5 | Smethurst Dominic | Chief Medical Off | — | $77.2K |
| 6 | Altmeyer Anne | Dir | — | $40.8K |
| 7 | Jenkins John Kenneth | Dir | — | $38.0K |
| 8 | Hodgson Ian | COO | — | $25.8K |
| 9 | Kung Winston | Dir | — | $16.0K |
| 10 | Ben Yong | Dir | — | $15.7K |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-10 16:30 | 2026-08-07 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | S - Sale | $10.08 | -12.0K | 84.7K | -12% | -$121.0K |
| T | 2026-02-18 | 2026-02-13 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | S - Sale | $7.78 | -4,701 | 96.7K | -5% | -$36.6K |
| D | 2026-01-16 | 2026-01-14 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | A - Grant | $0.00 | +28.1K | 101.4K | +38% | $0 |
| DT | 2025-10-27 | 2025-10-24 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | S - Sale+OE | $17.02 | -13.0K | 73.3K | -15% | -$220.9K |
| DT | 2025-10-27 | 2025-10-24 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | M - OptEx | $4.26 | +13.0K | 86.3K | +18% | +$55.3K |
| T | 2025-02-18 | 2025-02-14 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | S - Sale | $8.76 | -2,792 | 73.3K | -4% | -$24.5K |
| D | 2025-02-04 | 2025-01-31 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | A - Grant | $0.00 | +27.5K | 76.1K | +57% | $0 |
| DMT | 2024-06-18 | 2024-06-14+ | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | S - Sale+OE | $47.87 | -18.0K | 48.6K | -27% | -$863.8K |
| DMT | 2024-06-18 | 2024-06-14+ | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | M - OptEx | $12.96 | +18.0K | 56.4K | +47% | +$233.8K |
| D | 2024-04-11 | 2024-04-10 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | M - OptEx | $30.00 | +1,787 | 48.6K | +4% | +$53.6K |
| D | 2024-02-14 | 2024-02-12 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | A - Grant | $0.00 | +40.2K | 46.8K | +605% | $0 |
| 2022-08-10 | 2022-08-10 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | P - Purchase | $0.26 | +20.0K | 199.3K | +11% | +$5,200 | |
| 2022-05-16 | 2022-05-16 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | P - Purchase | $0.3 | +12.0K | 179.3K | +7% | +$3,600 | |
| 2022-03-10 | 2022-03-10 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Moran Sean F. | CFO | P - Purchase | $0.37 | +15.0K | 167.3K | +10% | +$5,550 |
Purchase Sale Sale after option exercise All abbreviations